Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-16

Clinical Trial Update: The Impact of Addition of Curcumin for 10 Days Triple Therapy, on the Eradication Rate of Helicobacter Pylori Infection [NA]

View source ↗

Summary

This clinical trial update evaluates whether adding curcumin to a 10-day triple therapy improves eradication of Helicobacter pylori infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (curcumin)

Snippet

Sponsor: Gingold Belfer Rachel | Conditions: Positivity for Helicobacter Pylori | NA | Status: UNKNOWN